Showing results (1341-1350 of 5,587) with videos related to

Sort By:
Pageof 559
Nuclear Medicine Communications|April 7, 2026
Quantitative [18F]-fluorodeoxyglucose PET analysis with a Gaussian normative templateZhilin Qian, Bomeng Du, Fang Wan, et al.
Nuclear Medicine Communications|March 3, 2026
Is nuclear medicine staffs' perception of risk following a 500 mSv skin dose incident from a Tc-99m source or a Ra-223 source correct?William H Thomson, Joseph Burmiston, Jenny D Thompson-Peters, et al.
Nuclear Medicine Communications|April 10, 2026
Pilot feasibility study investigating 68Ga-NODAGA-RGD PET-computed tomography molecular angiogenesis imaging in patients with peripheral arterial diseases: can it be of potential clinical value?Vishwajeet Jadhav, Priyanka Verma, Ashok Chandak, et al.
Nuclear Medicine Communications|April 10, 2026
Added value of maximum standardized uptake value and diffusion-weighted imaging in staging of high risk breast cancer patients using simultaneous 18F-flurodeoxyglucose positron emission tomography and magnetic resonance imagingPadma Subramanyam, Shanmuga Sundaram Palaniswamy, Sibiraj Hemant Patel
Nuclear Medicine Communications|April 7, 2026
Prognostic value of preoperative gallium-68 prostate-specific membrane antigen PET/computed tomography in predicting biochemical recurrence after radical prostatectomyHüseyin Mert Durak, Adem Sanci, Emre Hepşen, et al.
Nuclear Medicine Communications|April 7, 2026
Bibliometric analysis of programmed death ligand-1 positron emission tomography probe research: development, landscape, and technological evolutionKaixian Lin, Meina Li, Yaofeng Wang, et al.
Nuclear Medicine Communications|April 7, 2026
P2X7 receptor and neuroinflammation in neurodegenerative disorders: an autoradiography study with [18F]JNJ-64413739Abhishekh Hulegar Ashok, Sophie Field, Nisha Kuzhuppilly Ramakrishnan, et al.
Nuclear Medicine Communications|June 2, 2026
Effects of apolipoprotein E ε4 on amyloid deposition and relative cerebral perfusion in cognitively normal individuals: a dual-phase 18F-florbetaben PET studyJi-Young Kim, Donghyeon Kim, Geon Ha Kim, et al.
Nuclear Medicine Communications|June 3, 2026
Thyroid protection for 123I meta-iodobenzylguanidine and 123I ioflupane (DaTScan) diagnostic imaging: historical context, current evidence, and clinical perspectivesArash Latifoltojar, Dimitrios Priftakis, Saima Riaz, et al.
Nuclear Medicine Communications|June 3, 2026
Grading and detecting gastroenteropancreatic neuroendocrine neoplasms with dual-tracer ( 18 F-AlF-NOTA-octreotide/ 18 F-FDG) PET/CT: a metabolic parameter-based studyQing Dong, Qiuchen Zhou, Yang Liu, et al.
Pageof 559